Aurobindo Pharma Limited has informed the Exchange about Copy of Newspaper Publication
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has launched a buyback of up to 54,23,728 equity shares at Rs. 1,475 per share, totaling up to Rs. 800 crore. The buyback is being conducted via the tender offer route through the stock exchange mechanism. The record date for eligible shareholders was April 17, 2026, and the Letter of Offer was electronically dispatched on April 21, 2026. The offer opening advertisement was published on April 22, 2026 in English, Hindi, and Telugu newspapers. A corrigendum also corrects the premium over the volume-weighted average price to 12.72% instead of the earlier stated 13.18%.
The buyback signals management confidence and returns capital to shareholders at a premium to market price, which is typically positive for shareholder value. Shareholders who tender will receive Rs. 1,475 per share.